Are you for or against eConsent? It’s odd that this technology has kind of become a polarizing topic in the clinical trials industry. To find out why, I decided to get some feedback from folks who have actually used it.
- How To Choose Fit-For-Purpose Tech With The Modified Delphi Method
- Early Planning Trumps eCOA Bells & Whistles
- Why We Need Technology Consolidation In Clinical Trials
- Is Blockchain The Solution To Derisking Unreliable Clinical Trial Data?
- A Quick & Easy Guide To Site-Facing Clinical Trial Technologies
- What Sites Need: Trial Technology Integration, Support, And Evaluation
- Some Truths You Can't Avoid About eCOA
- What Sites Need: Trial Technology Selection, Buy-In, And Implementation
ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
Implementing eSource: A Guide For Operations And Technology Roles
By recognizing and addressing the challenges associated with eSource integration, research facilities can fully harness its transformative potential, optimizing efficiency and reliability.
-
How Small And Mid-Sized Biopharmaceutical Companies Can Easily Achieve Digital Innovation For Their Clinical Data
Discover how forward- thinking life science companies are defining their vision and looking for like-minded partners to execute information technology.
-
Electronic Data Capture In Clinical Trials: What Needs To Improve?
Integrated technologies enhance clinical trial support, boosting the potential for quicker time-to-market. Key sponsors and CROs favoring operational efficiency prioritize "holistic study design," involving the integration of technologies (e.g., EDC, eCOA, and IRT) aligned with protocol, as opposed to constructing the study in individual tools.
-
4 Key eCOA Benefits To Speed Up Your Clinical Trial
As the healthcare landscape moves towards a patient-centric approach, explore how sponsors and regulatory bodies look to eCOAs more and more for obtaining patient data.
-
eCOA Predictions For 2022
Dive into the prediction that the rapid adoption of eCOAs will continue to grow in 2022, as sponsors acknowledge how useful these tools have become in decentralized clinical trial (DCT) settings.
-
5 Features to Look for in Your Next eTMF
Not every electronic trial master file will provide the robust support and compliance measures required. When searching for a successful solution, make sure the eTMF of interest has these five features.
-
Implementing Cognizant® Shared Investigator Platform: Lessons From The Field
One leading oncology healthcare system and research institution has recently successfully implemented Cognizant SIP and shares its best practices around planning for and implementing Cognizant SIP given such a large footprint.
-
Using IRT Data To Automate And Optimize Clinical Supply
Learn how clinical teams can save between $150,000 and $1 million in annual drug and shipping costs through automated supply optimization.
-
Re-Consent In Clinical Trials: Streamlining With eConsent
Delve into a variety of triggers for initiating re-consent, perspectives of regulators and IRBs regarding the re-consent process, and the role of digital processes in preventing issues related to re-consent.
-
Benefits Of Using ePRO In Early Phase Studies
Discover how harnessing Patient Reported Outcomes electronically in early-phase trials can boost patient centricity, create more cost-effective operations, and help generate better data faster.
FREE E-BOOK
ISR Reports recently conducted research to understand the pharma industry’s experiences with clinical technology providers. Based on their findings, they created Industry Perspectives On Clinical Technologies, an e-book that discusses characteristics to consider when selecting an IRT provider, why sponsors use more than one CTMS solution, the future of EDC, and more.
Read The E-book!